Related Experiment Videos
Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant
The American Journal of Pediatric Hematology/Oncology
|May 1, 1992
Insights
Severe Factor X deficiency in a child led to intracranial hemorrhage. Prophylactic therapy with prothrombin complex infusions successfully prevented further bleeding, potentially improving outcomes for these patients.
Area of Science:
- Hematology
- Pediatric Medicine
- Coagulation Disorders
Background:
- Severe Factor X deficiency is a rare inherited bleeding disorder.
- Intracranial hemorrhage (ICH) is a serious complication in patients with severe Factor X deficiency, often leading to poor outcomes.
Observation:
- A pediatric patient presented with three episodes of intracranial hemorrhage within the first six months of life.
- The child was diagnosed with severe Factor X deficiency.
Findings:
- Successful management was achieved using prophylactic therapy with prothrombin complex concentrate infusions.
- The prophylactic regimen was administered via an indwelling central venous line.
Implications:
- Prophylactic therapy may significantly reduce the incidence of ICH in severe Factor X deficiency.
- This approach offers a potential strategy to prevent the historically poor outcomes associated with this condition in pediatric patients.
- Early and consistent prophylactic treatment is crucial for managing severe Factor X deficiency and preventing life-threatening bleeds.
Abstract:
We describe a case of a child with severe Factor X deficiency who had three episodes of intracranial hemorrhage during the first 6 months of life. Since that time he has been successfully managed with prophylactic therapy using prothrombin complex infusions via an indwelling central venous line. This prophylactic therapy may prevent the poor outcome usually described in these patients.